Similarly, no variations in mRNA and protein levels of SHP-2 were observed in the ischemic muscle of T1D mice compared to ischemic controls, suggesting that SHP-2 might have a lesser impact than SHP-1 in collateral vessel formation in diabetic PAD (41, 42). Here, PTPN11 is linked to peripheral arterial disease.